iScience 2019 Credit Information,
Terms of Service, and License Agreement
Terms of Service and License Agreement set forth below constitute a legal
agreement (collectively, the "Agreement") between the American
College of Cardiology Foundation ("ACCF") and You and your agents
("You" or "Your") for the use of the iScience 2019 (the
clicking on the Agree button below, and by using the Product, You accept and
agree to be bound by all of the terms and conditions set forth in this
Agreement. If You do not wish to accept the terms and conditions of this
Agreement, You may not proceed to use the Product.
may change the terms of this Agreement from time to time without further notice
directly to You. When the terms are changed, ACCF will post a general
conspicuous notice. If You do not agree with the revised terms, please
discontinue use of the Product immediately. Your continued use of the Product
following such notice constitutes your acceptance of and agreement to be bound
by any revised terms of the Agreement. This Agreement expressly incorporates by
reference and includes any and all rules or disclaimers that may be posted and
updated within the Product or communicated to You from time to time.
Information Regarding this
iScience, the ACC.19 Meeting On Demand™
Program is a digital library of more than 360 hours of educational content
presented at the ACC.19 meeting.
Features of iScience include:
- Presenters' slides
with synchronized audio
- Searchable slide
- Earn up to
100 AMA PRA Category 1 Credits™, CNE contact hours, CPE
credits, and/or ABIM Medical Knowledge MOC points
- C and MAC
- Online access and
offline access with hard drive
- Mobile version for
most tablets and smartphones
- MP3 and PDF
iScience includes key educational
sessions including Late-Breaking Clinical Trials and highlights from all 10
- Acute and Stable
Ischemic Heart Disease
- Arrhythmias and
- Congenital Heart
- Heart Failure and
- Pulmonary Hypertension
and Venous Thromboembolic Disease
- Valvular Heart
- Vascular Medicine
Grant Acknowledgments: No
educational grants were provided for this activity.
iScience is intended for all professionals
involved in delivering cardiovascular care, with particular emphasis on
physicians, scientists, nurse practitioners, clinical nurse specialists,
physician assistants, nurses, pharmacists, and practice administrators. Medical
students and trainees, technicians, dietitians and other health care
professionals will also benefit.
Accreditation for Physicians
American College of Cardiology Foundation is accredited by the Accreditation
Council for Continuing Medical Education to provide continuing medical education
ACCF designates this enduring material for a maximum of 100 AMA PRA Category 1
Credits™. Physicians should claim only the credit commensurate with the extent
of their participation in the activity.
Maintenance of Certification
completion of this CME activity, which includes participation in the evaluation
component, enables the participant to earn up to 100 Medical Knowledge MOC
points in the American Board of Internal Medicine's (ABIM) Maintenance of
Certification (MOC) program. It is the CME activity provider's responsibility
to submit participant completion information to ACCME for the purpose of
granting ABIM MOC credit.
Accreditation for Nurses
American College of Cardiology Foundation is accredited as a provider of
continuing nursing education by the American Nurses Credentialing Center’s
Commission on Accreditation (Provider No. P0019).
ACCF designates this activity for 100 CNE contact hours. Nurses should claim
only the credit commensurate with the extent of their participation in this
Accreditation for Pharmacists
Joint Accreditation Statement
support of improving patient care, this activity has been planned and
implemented by the Postgraduate Institute for Medicine and American College of
Cardiology Foundation. Postgraduate Institute for Medicine is jointly
accredited by the Accreditation Council for Continuing Medical Education
(ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the
American Nurses Credentialing Center (ANCC), to provide continuing education
for the healthcare team.
Continuing Pharmcy Education
Institute for Medicine designates this continuing education activity for 100.0
contact hour(s) (10.0 CEUs) of the Accreditation Council for Phamacy
offering the credits noted above, this program is not intended to provide
extensive training or certification in the field.
Activity Numbers: See evaluation survey for specific details.
*Please Note: If you already claimed credit for attending the
ACC.19 meeting in New Orleans, you may not claim credit for the same session(s)
in iScience. Physicians are allowed to claim CME, and/or MOC credit, Nurses can
claim CNE contact hours, and Pharmacists can claim CPE credit.
Method of Participation and
product offers up to 100 AMA PRA Category 1 Credits™, CNE contact
hours, CPE credits, and/or ABIM Medical Knowledge MOC points based on the
number of hours you spend watching presentations and taking the post-test
questions. You may re-enter the product as many times as you wish, but
you can claim credit only once and must claim credit by March 16, 2020.
receive credit for this product, you must:
2. Read the
Credit Information when you first enter the player or by clicking the Credit
Information link in the top right corner.
3. View the
session(s) of your choosing.
4. Click the
Credit/Test link in the top right corner after you have completed viewing all
sessions for which you intend to claim credit.
the posttest. You must score 70% to earn credit, but you can re-take test
questions that you missed as many times as necessary.
6. Enter the
number of credits you wish to claim. Credits claimed should reflect the
total number of hours that you spent reviewing the Credit Information, watching
sessions and taking the posttest.
7. If you are
an ABIM Diplomate, you will then be asked to enter your ABIM ID and Date of
Birth to claim MOC points. If you do not wish to claim MOC points, you can
choose to not claim.
and print your certificate. If you are an ABIM Diplomate and claimed MOC
points, your completion information will be transmitted to the ACCME/ABIM on
you already claimed credit for attending the live ACC.19 meeting, you may not
claim credit for the same sessions on iScience.
of Release: March 17, 2019
of Approval / Date of Expiration: March 16, 2020
note that credit will only be available through the term of approval noted
above, although you may continue to access iScience 2019
online through March 16, 2021.
Media or Combination of Media Used:
iScience is available in the following
- Online access with
downloadable MP3 files and PDF files
- External hard drive
- Mobile version for
most tablets and smartphones
visit iScience.acc.org, and
Requirements for the most up-to-date system requirements.
ACCF Learner Bill of Rights
ACCF recognizes that You are a life- long learner who has chosen to engage in
continuing medical education to identify or fill a gap in knowledge or skill;
and to attain or enhance a desired competency. As a participant in an ACCF
activity, You have the right to expect that your continuing medical education
experience with ACCF includes the following:
improvements or quality in healthcare.
- Is current, valid,
reliable, accurate and evidence-based.
- Addresses the
stated objectives or purpose.
- Is driven and based
on independent survey and analysis of learner needs, not commercial
- Has been reviewed
for bias and scientific rigor.
- Offers balanced
presentations that are free of commercial bias.
- Is vetted through a
process that resolves any conflicts of interest of planners and faculty.
- Is evaluated for
its effectiveness in meeting the identified educational need.
A learning environment that:
- Is based on adult
learning principles that support the use of various modalities.
- Supports learner’s
abilities to meet their individual needs.
- Respects and
attends to any special needs of the learners.
- Respects the
diversity of groups of learners.
- Is free of
promotional, commercial and/or sales activities.
- Relevant financial relationships
that planners, teachers and authors have with commercial interests related
to the content of the activity.
- Commercial support
(funding or in-kind resources) of this activity.
Program Goals and Learning
Objectives by Learning Pathway
is dedicated to providing needs-based education that is independent of
commercial interests and fosters change in learners’ knowledge, competence and
performance to ultimately improve patient outcomes. The overall goals for
- To facilitate
translation of cardiovascular science to all members of the care team
leading to high-quality, patient-centered care
- To allow for
examination and discussion of important contributions and controversies in
- To promote
cardiovascular science and education to a global audience
Acute and Stable Ischemic Heart Disease
a result of participating in the Acute and Stable Ischemic Heart Disease
Pathway sessions, learners will have an improved or reinforced ability to...
and contrast different STEMI and NSTEMI systems of care and logistical
processes for managing complex patients with ACS
a differential diagnosis and management strategy for athletes presenting with
ischemic heart disease
the methodology of recent acute and stable ischemic heart disease clinical
trials to determine the implications and generalizability of findings
the evidence and different perspectives underlying current controversies in
acute and stable ischemic heart disease diagnosis and management and ACS
Guidelines, including international and other societal guidelines
the management of complications seen in ischemic heart diseases
barriers to implementation of cardiac rehab and novel approaches
7. Assess and
appropriately manage patients with cardiogenic shock or in need of critical
8. Detect and
manage patients with angina refractory that are resistant to conventional
the diagnosis and management of atypical ischemic heart disease presentations,
including microvascular dysfunction, spontaneous coronary artery dissection,
and ischemia without obstructive coronary artery disease
cutting-edge approaches towards genetic testing for coronary artery disease
Arrhythmias and Clinical EP
a result of participating in the Arrhythmias and Clinical EP Pathway sessions,
learners will have an improved or reinforced ability to...
recent evidence and current guideline recommendations to the management of
emerging evidence and options for prevention, detection, risk assessment,
rhythm and rate management, and stroke prevention into the care of patients
with atrial fibrillation
and contrast pharmacologic management and treatment of arrhythmias, including
outcomes and risk of adverse events due to medications used to treat
patients and patient populations who can benefit from currently available
and interpret salient ECG patterns and integrate into clinical decision-making
symptoms (eg. syncope) that arise due to arrhythmias in special populations,
including in athletes, inherited arrhythmia conditions, pregnancy, and
current findings from clinical trials and future implications in research
topical health trends and advancing technology utilized by both clinicians and
patients, and implication on diagnosis and management of arrhythmias
Congenital Heart Disease
a result of participating in the Congenital Heart Disease (CHD) Pathway
sessions, learners will have an improved or reinforced ability to...
strategies to effectively evaluate and manage acquired pediatric heart disease
innovative therapies and complex clinical scenarios in fetal cardiology
the role of novel transcatheter therapies and surgical techniques in the
management of CHD
evaluate emerging imaging applications in CHD
recent advances and research into cardiology practice for CHD
challenging issues in heart failure management and electrophysiology in
children and adults
7. Review the
contemporary management of pregnancy and other women's health issues in
patients with CHD
Heart Failure and Cardiomyopathies
a result of participating in the Heart Failure and Cardiomyopathies Pathway
sessions, learners will have an improved or reinforced ability to...
contemporary concepts in cardiovascular pathophysiology with evidence-based
strategies in the diagnosis, evaluation, and management across the entire
spectrum of patients with heart failure and cardiomyopathy
practical guidance on diet, exercise, support, and heart failure management
that is appropriately tailored to diverse patient populations across various
stages and types of heart failure
the interaction between various comorbidities and heart failure, and best
practices in the multidisciplinary approach
the role and indications for ICDs, CRTs, hemodynamic sensors, and mechanical
support for heart failure management
knowledge in the evidence-based care of patients with infiltrative and
inherited cardiomyopathy, and less common inherited and acquired
the evidence on current and newer pharmacotherapies, devices, and therapies for
best practices heart failure management
future approaches to heart failure and cardiomyopathy diagnosis and management
insight to address the needs of specific patient populations with heart failure
and cardiomyopathy, and at different stages of life
a result of participating in the Interventional Cardiology Pathway sessions,
learners will have an improved or reinforced ability to...
an appropriate antithrombotic regimen for diverse patients with acute coronary
syndrome or undergoing a revascularization procedure, and address issues with
antiplatelet regimens in patients at high risk for bleeding
and integrate findings from adjunctive coronary and endovascular assessment
into clinical decision-making
whether and how to revascularize patients who are high-risk or have complex
coronary artery disease
the evidence from clinical trials describing outcomes, recent advances, and
expanded applications of angiography and interventional cardiology
key tactics for preventing and managing interventional complications
incorporate new and state-of-the-art structural heart and endovascular
technologies and techniques into patient care
effectively as part of a comprehensive care team to manage patients before,
during, and after interventional procedures
findings from diagnostic imaging to plan treatment, guide intervention, and
gauge procedural outcomes
a result of participating in the Noninvasive Imaging Pathway sessions, learners
will have an improved or reinforced ability to...
current imaging guidelines for the assessment of valvular, myocardial,
coronary, pericardial, and complex congenital and structural heart diseases
both current and emerging roles of stress echocardiography for evaluating heart
recent innovations in advanced imaging techniques and their potential
findings from non-invasive imaging to clarify the etiology and guide the
management of patients with heart failure or cardiomyopathy and systemic
diseases involving the heart (e.g., cardiac amyloidosis, sarcoidosis)
the prognostic implications of cardiac CT and cardiac MRI findings and their
appropriate impact on patient management
a result of participating in the Prevention Pathway sessions, learners will
have an improved or reinforced ability to...
current evidence base to determine thresholds for hypertension treatment,
establish therapeutic goals, and implement team-based processes to achieve
blood pressure control in simple and complex cases
the implications of diabetes on cardiovascular disease and tailor management
strategies based on available evidence
the underlying evidence on dyslipidemia and ASCVD, including targeting novel
pathways and the controversies in dyslipidemia management.
best practices with regards to lifestyle and dietary recommendations to prevent
or manage ASCVD and related diseases, such as diabetes
unique factors in prevention and management of ASCVD for vulnerable populations
and the disparities in current research and guidelines
current cholesterol and other ASCVD prevention guidelines in practice
Pulmonary Hypertension and Venous Thromboembolic Disease
a result of participating in the Pulmonary Hypertension and Venous
Thromboembolic Disease Pathway sessions, learners will have an improved or
reinforced ability to...
the diagnostic and therapeutic options for patients with pulmonary hypertension
and the multiple potential etiologies of pulmonary hypertension
innovative translational discoveries and the potential for personalized
medicine in PAH
current practice and innovative research to the cardiology practice for patient
population with VTE
shared decision making and adjunctive resources in caring for patients with
Valvular Heart Disease
a result of participating in Valvular Heart Disease (VHD) Pathway sessions,
learners will have an improved or reinforced ability to...
recent updates to guidelines and recommend best practices for valvular care to
how the mechanism, natural history, diagnosis and treatment options of patients
with valve disease continue to evolve and affect patient care algorithms
3. Assess the
role of imaging and physiologic testing in characterizing valvular disease and
the heart team approach to treatment of patients with VHD
the evidence on contemporary diagnostic and treatment options into clinical
decision-making for patients with VHD
strategies in assessment, diagnosis and treatment of special populations with
valvular heart disease
a result of participating in Vascular Medicine Pathway sessions, learners will
have an improved or reinforced ability to...
the evidence associated with current management of vascular diseases
recent clinical trial findings and evidence-based guideline recommendations
into the treatment of patients with vascular disease, including special
effective treatment of common vascular and thrombotic complications of cancer
and cancer-directed therapy
TERMS OF SERVICE AND
Term of Access and Termination
acknowledge and agree that the Product is being provided to you online for a
limited period of time, and that You will have access to the Product online
through March 16, 2021. Your access to the Product will terminate upon the
expiration of this specified period of time. ACCF may terminate your
access and/or the Product at any time for reasonable cause, upon notice to You.
You agree that any such termination of your access to the Product shall not result
in any liability or other obligation of ACCF to You, or any third party in
connection with such termination.
Intellectual Property Rights
Product, including the information, text, graphics, images, audio and video
files, trademarks and other materials that may be contained therein
(collectively "Content"), and all right, title and interest therein,
including copyright and all rights subsumed thereunder, is owned by ACCF, and
to the extent any Content is not owned by ACCF, ACCF has obtained sufficient
rights and permissions to include such Content in the Product. The
Content is protected by patents, copyrights, trademarks, and other proprietary
rights. Except as otherwise specifically provided in this Agreement, your use
of the Product shall be governed and constrained by applicable patent,
copyright, trademark and other intellectual property laws. ACCF grants
You a limited, nonexclusive, nontransferable, non-sublicenseable, revocable
license to utilize and access the Product for Your noncommercial, personal use
according to the terms and conditions in this Agreement. You may not modify,
publish, transmit, participate in the transfer or sale of, reproduce, create
derivative works from, distribute, perform, display, incorporate into another
website or any other medium, or in any other way exploit the Product and/or any
of the Content, in whole or in part. Except as expressly granted by this
Agreement, You acquire no right, title or interest in or to the Product or the
Content or other data or materials incorporated in the Product. ACCF, American
College of Cardiology (“ACC”), and any affiliates or licensors thereof shall
retain all right, title and interest in the Product and Content.
is not responsible for statements made by any contributor to the Product or for
any errors or omissions or for the results obtained from use of the information
contained in this Product. Statements or opinions expressed in this Product
reflect the views of the contributors and do not reflect the official policy of
ACCF or ACC. The Product and Content are provided on an “as is” and “as
available” basis. ACCF and ACC expressly disclaim all warranties of any
kind with respect to the Product or Content, whether express or implied,
including implied warranties of merchantability, fitness for a particular
purpose, title and non-infringement. ACCF makes no warranty that the
Product and/or any Content therein will meet Your requirements, or will be
accurate, complete or error-free, and further does not warrant that the results
that may be obtained by Your use of the Product or any Content therein will be
accurate or reliable.
Content on the Product is presented as an educational service intended for
licensed healthcare professionals. While the Content in the Product is about
specific medical and healthcare issues, the Content is not a substitute for or
replacement of personalized medical advice and is not intended to be used as
the sole basis for making individualized medical or health-related decisions.
are advised to independently ensure that any recommended drug dosages in the
Product concur with the information provided in the drug product information
material. Application of the information in Product remains the sole
professional responsibility of the practitioner and ACCF hereby expressly
disclaims responsibility for any liability arising from or in connection with
the application of the information in the Product by You.
views and opinions expressed in the Product are those of the contributing
authors and editors and do not necessarily represent the views of the ACCF. The
material is not intended to present the only, or necessarily best, methods or
procedures for the medical situations addressed, but rather is intended to
represent an approach, view, statement or opinion.
reference to a specific therapy or commercial product in this Product does not
constitute a guarantee, warranty, or endorsement by ACCF or ACC of the quality
or value of such therapy or product, or a guarantee, warranty or endorsement by
ACCF or ACC of any claims made by the manufacturer of such therapy or
Unapproved Use Disclosure
Product may include discussion about pharmaceutical agents and/or medical
devices/products that are outside of U.S. Food and Drug Administration approved
labeling. This information is intended solely for continuing medical education
and is not intended to promote off-label use of these pharmaceutical agents
and/or medical devices/products. If You have questions, contact the medical
affairs department of the manufacturer for the most recent information.
Nothing herein is intended to be a promotion, endorsement, guarantee or
warranty by ACCF of any such pharmaceutical agents and/or medical
Disclosure/Conflict Of Interest
a provider accredited by the ACCME and the ANCC, ACCF must ensure balance,
independence, objectivity and scientific rigor in all of its directly provided
or jointly provided/co-provided educational activities. Planners, presenters,
and other contributors in a position to control the Content included in the
Product are required to disclose to ACCF all relevant financial or other
material relationships or interests he/she and/or his/her spouse or domestic
partner may have, occurring within the past twelve (12) months, with any entity
producing, marketing, re-selling, or distributing health care goods or services
consumed by, or used on, patients. When an unlabeled use of a commercial
product or an investigational use not yet approved for any purpose is discussed
during an educational activity, ACCF requires the inclusion of a disclosure
statement that the product is not labeled for the use under discussion or that
the product is still investigational.
is committed to providing its learners with high-quality activities and
materials that promote improvements and quality in health care, rather than a
specific proprietary business or commercial interest. The intent of ACCF’s
required disclosure is not to prevent participation in certified educational
activities by persons with a financial or other material relationship with
entities producing, marketing, re-selling, or distributing health care goods or
services consumed by, or used on, patients, but rather to provide learners with
information on which they can make their own determination whether financial
interests or material relationships may influence the certified activity.
assesses potential conflicts of interest disclosed by its faculty,
contributors, planners, managers, staff and other individuals who are in a
position to control the content of certified activities. All relevant potential
conflicts of interest that are identified are thoroughly vetted through a
process conducted by activity course directors, ACCF education staff, and
members of the Accreditation Compliance Workgroup and that includes appropriate
peer review for fair balance, scientific objectivity and validity, and patient
care and safety recommendations.
staff involved with this activity have nothing to disclose.
Click here to see a list of
disclosures for everyone involved in planning and presenting at ACC.19.
Intent of Question and Answer Section
question and answer section of the Product was designed to stimulate thinking
and motivate You to further research. Answers and commentary are based on the
best judgment of the authors and contributors at the time the question was
written. New knowledge, insights and perspectives may cause You to disagree
with an author's answer. ACCF encourages thoughtful discussion and
consideration of each question's answer and commentary. While most of the
questions within the Product link back to related text, not all of them do. The
ACCF Editorial Team’s philosophy is that questions are an opportunity to make
an additional teaching point outside of the text or to incite the user to learn
something above and beyond the text.
Release of Liability
hereby agree to assume all risks associated with use of the Product including,
but not limited to any harm, injury or damages resulting directly or indirectly
from the use of the Product, all such risks being known and understood by You.
In consideration of your use of the Product, You, for yourself, your
successors, assigns and anyone entitled to act on your behalf, waive and
forever release and discharge ACCF, its officers, trustees, employees,
representatives and successors from any and all claims and liabilities of any
kind arising out of or in connection with Your use or misuse of the Product.
hereby agree to indemnify, save and hold ACCF, its directors, officers,
shareholders, parents, subsidiaries, affiliates, agents and licensors harmless
from and against any and all claims, liability, losses, damages and costs,
including, without limitation, reasonable attorneys' fees and costs, arising
out of or in connection with Your use or misuse of the Product or Content, or
any violation of this Agreement. ACCF assumes the right, at Your expense,
to assume the exclusive defense and control of any matter for which You are
required to indemnify ACCF, and You agree to cooperate with ACCF’s defense of
these claims. ACCF will use reasonable efforts to notify You of any such
claim, action, or proceeding upon becoming aware of it.
Agreement is personal to You, and You may not assign your rights or obligations
to any other individual or entity. Neither failure nor delay on the part
of any party to exercise any right, remedy, power or privilege hereunder nor
course of dealing between the parties shall operate as a waiver thereof, or of
the exercise of any other right, remedy, power or privilege. No term of this
Agreement shall be deemed waived, and no breach consented to, unless such
waiver or consent shall be in writing and signed by the party claimed to have
waived or consented. No waiver of any rights or consent to any breaches shall
constitute a waiver of any other rights or consent to any other breach.
If any provision in this Agreement is held invalid or unenforceable under
applicable law, the remaining provisions shall continue in full force and
effect. This Agreement will be governed by and construed exclusively in
accordance with the laws of the District of Columbia, USA, without regard to
its conflicts of law principles and, to the extent applicable, the federal laws
of the United States.
Provider Contact Information:
(818) 844-3299; Toll Free (800) 501-2303 (U.S.A. only)
For questions about ACC activities:
Member Care at (202) 375-6000, ext. 5603 or (800) 253-4636, ext. 5603.
ACC Policy on Privacy and Confidentiality:
Copyright ©2019 American College of
obey all copyright laws.
in the USA.
part of this Product may be reproduced or transmitted in any form or by any
means, electronic or mechanical, including photocopying, recording, or any
information storage or retrieval system without permission in writing from the
American College of Cardiology Foundation.